Casteel H B, Fiedorek S C
Division of Pediatric Gastroenterology and Nutrition, University of Arkansas for Medical Sciences, Little Rock.
Pediatr Clin North Am. 1990 Apr;37(2):295-311. doi: 10.1016/s0031-3955(16)36869-9.
Diarrhea is a major cause of mortality and morbidity affecting infants and children in many parts of the world. Research and understanding of normal and abnormal gastrointestinal physiology allowed the development of oral electrolyte solutions to treat dehydration. These solutions were initially used for treatment of cholera in areas with poor access to medical care and are now used extensively by the WHO. Therapy with OES has expanded to other nonsecretory causes of diarrhea. Two types of solutions are available in the United States. Maintenance solutions contain 40 to 60 mEq per liter of sodium and are used for prevention of dehydration or after rehydration. Rehydration solutions contain 60 to 90 mEq per liter of sodium and are effective for the oral repletion of fluid and electrolyte deficits in both secretory and nonsecretory diarrhea.
腹泻是影响世界许多地区婴幼儿死亡率和发病率的主要原因。对正常和异常胃肠生理学的研究与理解促使了口服电解质溶液的研发,用于治疗脱水。这些溶液最初用于医疗资源匮乏地区的霍乱治疗,现在被世界卫生组织广泛使用。口服电解质溶液疗法已扩展至其他非分泌性腹泻病因。美国有两种类型的溶液。维持液每升含40至60毫当量钠,用于预防脱水或补液后使用。补液液每升含60至90毫当量钠,对分泌性和非分泌性腹泻的液体和电解质缺乏进行口服补充均有效。